Toshiaki Yamanaka Selected Research

Ischemia

1/2015

Remote ischemic preconditioning reduces contrast-induced acute kidney injury in patients with ST-elevation myocardial infarction: a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshiaki Yamanaka Research Topics

Disease

7	Meniere Disease (Menieres Disease) 02/2020 - 07/2015
6	Vertigo (Positional Vertigo) 08/2022 - 08/2004
4	Dizziness (Lightheadedness) 08/2022 - 01/2019
4	Endolymphatic Hydrops 09/2020 - 01/2019
2	Hearing Loss (Hearing Impairment) 03/2023 - 01/2018
2	Infections 03/2023 - 10/2013
2	Myocardial Infarction 01/2023 - 01/2015
2	Vertebrobasilar Insufficiency 05/2014 - 08/2004
2	Head and Neck Neoplasms (Head and Neck Cancer) 11/2005 - 08/2003
1	Cytomegalovirus Infections (Inclusion Disease) 03/2023
1	Peripheral Arterial Disease 01/2023
1	Stroke (Strokes) 01/2023
1	Orthostatic Hypotension (Postural Hypotension) 08/2022
1	Neoplasm Metastasis (Metastasis) 09/2021
1	Anaplastic Thyroid Carcinoma 08/2021
1	Paresis (Hemiparesis) 04/2019
1	Coronary Aneurysm (Aneurysm, Coronary) 07/2018
1	Pathologic Dilatation (Ectasia) 07/2018
1	Aneurysm (Aneurysms) 07/2018
1	Rupture 07/2018
1	Ischemia 01/2015
1	ST Elevation Myocardial Infarction 01/2015
1	Acute Kidney Injury (Acute Renal Failure) 01/2015
1	Squamous Cell Carcinoma of Head and Neck 03/2014
1	Lipoma (Lipomata) 01/2014
1	Taste Disorders (Taste Disorder) 01/2014
1	Neoplasms (Cancer) 01/2014
1	Osteoporosis 11/2013
1	Benign Paroxysmal Positional Vertigo 11/2013
1	Fistula 10/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011
1	Parkinson Disease (Parkinson's Disease) 01/2009
1	Hypoxia (Hypoxemia) 08/2004
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 08/2003
1	Carcinoma (Carcinomatosis) 08/2003

Drug/Important Bio-Agent (IBA)

4	SteroidsIBA 01/2019 - 07/2015
3	GadoliniumIBA 09/2020 - 12/2019
1	Valganciclovir FDA Link 03/2023
1	hydroxide ionIBA 08/2022
1	Dihydrotachysterol (AT 10)IBA 09/2021
1	lenvatinibIBA 08/2021
1	Glycerol (Glycerine)FDA LinkGeneric 09/2020
1	Polytetrafluoroethylene (Teflon)FDA Link 07/2018
1	Vasopressins (Vasopressin)IBA 01/2016
1	Hormones (Hormone)IBA 01/2016
1	salicylhydroxamic acid (SHAM)IBA 01/2015
1	Alprostadil (Muse)FDA LinkGeneric 05/2014
1	2- (2- methoxy- 4- nitrophenyl)- 3- (4- nitrophenyl)- 5- (2,4- disulfophenyl)- 2H tetrazolium monosodium saltIBA 03/2014
1	AldehydesIBA 03/2014
1	trans-crotonin (CTN)IBA 01/2014
1	Estrogens (Estrogen)FDA Link 11/2013
1	AcidsIBA 10/2013
1	Triglycerides (Triacylglycerol)IBA 01/2011
1	Glucose (Dextrose)FDA LinkGeneric 01/2011
1	Docetaxel (Taxotere)FDA Link 11/2005
1	ChloraloseIBA 08/2004
1	Glutamic Acid (Glutamate)FDA Link 08/2004
1	MLV 6976IBA 08/2004
1	titanium silicide (TS-1)IBA 08/2003

Therapy/Procedure

6	Therapeutics 08/2021 - 10/2013
2	Percutaneous Coronary Intervention 07/2018 - 01/2015
1	Surgical Amputation (Amputations) 01/2023
1	Exercise Therapy (Therapy, Exercise) 01/2023
1	Free Tissue Flaps 08/2021
1	Drug-Eluting Stents 07/2018
1	Stents 07/2018
1	Hearing Aids (Hearing Aid) 01/2018
1	Reoperation 07/2015
1	Tracheotomy 01/2014
1	Surgical Instruments (Clip) 01/2014
1	Drug Therapy (Chemotherapy) 10/2013
1	Deep Brain Stimulation 01/2009